These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36821697)

  • 1. Impact of Emend on Perioperative Bariatric Surgery Antiemetic Utilization, Patient Satisfaction, and Costs.
    Aghazarian GS; Lind R; Motola D; Perry M; Singletary N; Lastrapes L; Ghanem M; Jawad MA; Teixeira AF
    Surg Laparosc Endosc Percutan Tech; 2023 Jun; 33(3):265-269. PubMed ID: 36821697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.
    Piechotta V; Adams A; Haque M; Scheckel B; Kreuzberger N; Monsef I; Jordan K; Kuhr K; Skoetz N
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012775. PubMed ID: 34784425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery.
    Therneau IW; Martin EE; Sprung J; Kellogg TA; Schroeder DR; Weingarten TN
    Obes Surg; 2018 Jan; 28(1):37-43. PubMed ID: 28674839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: a prospective, randomized, double-blind study.
    Soga T; Kume K; Kakuta N; Hamaguchi E; Tsutsumi R; Kawanishi R; Fukuta K; Tanaka K; Tsutsumi YM
    J Anesth; 2015 Oct; 29(5):696-701. PubMed ID: 25801542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of intravenous fosaprepitant and ondansetron in the prevention of postoperative nausea and vomiting in patients who underwent lower limb surgery: a prospective, randomized, double-blind study.
    Kakuta N; Kume K; Hamaguchi E; Tsutsumi R; Mita N; Tanaka K; Tsutsumi YM
    J Anesth; 2015 Dec; 29(6):836-41. PubMed ID: 26210166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.
    Willier S; Cabanillas Stanchi KM; von Have M; Binder V; Blaeschke F; Feucht J; Feuchtinger T; Döring M
    BMC Cancer; 2019 Nov; 19(1):1118. PubMed ID: 31730451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial.
    Bergese S; Viloria A; Uribe A; Antor A; Fernandez S
    Trials; 2012 Aug; 13():130. PubMed ID: 22862827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative Antiemetic Therapy for Fast-Track Laparoscopic Bariatric Surgery.
    Bamgbade OA; Oluwole O; Khaw RR
    Obes Surg; 2018 May; 28(5):1296-1301. PubMed ID: 29116559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial?
    Tang J; Chen X; White PF; Wender RH; Ma H; Sloninsky A; Naruse R; Kariger R; Webb T; Zaentz A
    Anesthesiology; 2003 Feb; 98(2):293-8. PubMed ID: 12552184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosaprepitant for postoperative nausea and vomiting in patients undergoing laparoscopic gastrointestinal surgery: a randomised trial.
    Huang Q; Wang F; Liang C; Huang Y; Zhao Y; Liu C; Lin C; Zhang L; Zhou S; Wang Q; Li S; Gong R; Wu Q; Gu Y; Zhang J; Luo T; Wang W; Zhang S; Bizo Mailoga N; Wang K; Jin S; Zhao Y
    Br J Anaesth; 2023 Oct; 131(4):673-681. PubMed ID: 37423834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures: a randomized, double-blind, comparative trial.
    Chen JJ; Frame DG; White TJ
    Arch Intern Med; 1998 Oct; 158(19):2124-8. PubMed ID: 9801179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprepitant's prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery.
    Sinha AC; Singh PM; Williams NW; Ochroch EA; Goudra BG
    Obes Surg; 2014 Feb; 24(2):225-31. PubMed ID: 23990451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of Fosaprepitant and Ondansetron for Preventing Postoperative Nausea and Vomiting in Moderate to High Risk Patients: A Retrospective Database Analysis.
    Murakami C; Kakuta N; Kume K; Sakai Y; Kasai A; Oyama T; Tanaka K; Tsutsumi YM
    Biomed Res Int; 2017; 2017():5703528. PubMed ID: 29410964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy.
    Sadhasivam S; Saxena A; Kathirvel S; Kannan TR; Trikha A; Mohan V
    Anesth Analg; 1999 Dec; 89(6):1340-5. PubMed ID: 10589605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a disposable acupressure device as part of a multimodal antiemetic strategy for reducing postoperative nausea and vomiting.
    White PF; Zhao M; Tang J; Wender RH; Yumul R; Sloninsky AV; Naruse R; Kariger R; Cunneen S
    Anesth Analg; 2012 Jul; 115(1):31-7. PubMed ID: 22504214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.
    Habib AS; Gan TJ
    J Clin Anesth; 2005 Feb; 17(1):62-5. PubMed ID: 15721732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosaprepitant versus droperidol for prevention of PONV in craniotomy: a randomized double-blind study.
    Atsuta J; Inoue S; Tanaka Y; Abe K; Nakase H; Kawaguchi M
    J Anesth; 2017 Feb; 31(1):82-88. PubMed ID: 27757553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
    Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
    Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies.
    Cabanillas Stanchi KM; Ebinger M; Hartmann U; Queudeville M; Feucht J; Ost M; Koch MS; Malaval C; Mezger M; Schober S; Weber S; Michaelis S; Lange V; Lang P; Handgretinger R; Döring M
    Drug Des Devel Ther; 2019; 13():3439-3451. PubMed ID: 31686784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.